Forskning
Udskriv Udskriv
Switch language
Region Hovedstaden - en del af Københavns Universitetshospital
Udgivet

Increased risk of post-operative complications in patients with Crohn's disease treated with anti-tumour necrosis factor α agents - a systematic review

Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  1. Outcomes and follow-up programmes in extreme preterm children in Denmark in the EPICE/SHIPS cohort

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  2. Risk of pancreatitis in patients with inflammatory bowel disease - a meta-analysis

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  3. Danish expanded newborn screening is a successful preventive public health programme

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  4. Analgesics use and withdrawal in people with dementia - a register-based Danish study and a systematic review

    Publikation: Bidrag til tidsskriftReviewForskningpeer review

  5. Everolimus as adjunctive treatment in tuberous sclerosis complex-associated epilepsy in children

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  1. ECCO Guidelines on Therapeutics in Crohn's Disease: Surgical Treatment

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  2. Optimized thiopurine therapy before withdrawal of anti-tumour necrosis factor-α in patients with Crohn's disease

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  3. Point of care testing of fecal calprotectin as a substitute for routine laboratory analysis

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

Vis graf over relationer

INTRODUCTION: Tumour necrosis factor α (TNF-α) plays a role in the immune defence, angiogenesis and collagen synthesis. Inhibition of these pathways may increase the risk of infections and impair wound healing in patients after surgery. Biologic treatments including anti-TNF-α agents are increasingly used in the treatment of inflammatory bowel disease. Taking into consideration the biologics' mechanism of action, fears have been expressed that they might increase the rate of post-operative complications. Results from 18 retrospective studies were conflicting, and meta-analyses based on these studies did not agree. The objective of this study was to review data from present reviews and meta-analyses in an attempt to come to conclusions for the use of anti-TNF-α in Crohn's disease patients in clinical practice.

METHODS: Literature search using both electronic and manual searches was conducted according to a pre-defined protocol. Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA) guidelines were applied.

RESULTS: Two systematic reviews and six meta-analyses were found. Meta-analyses that included a large number of patients and applied quality assessment showed an increased risk of overall post-operative complications and an increased rate of infectious or anastomosis-related complications in patients receiving anti-TNF-α.

CONCLUSION: The use of anti-TNF-α agents in Crohn's disease patients is associated with an increased risk of post-operative complications after abdominal surgery.

OriginalsprogEngelsk
TidsskriftDanish Medical Bulletin (Online)
Vol/bind61
Udgave nummer12
Sider (fra-til)A4975
ISSN1603-9629
StatusUdgivet - dec. 2014

ID: 44896280